The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors

References

• Rosenberg SA , Restifo NP , Yang JC , Morgan RA , Dudley ME. Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008; 8(4): 299-308; PMID:18354418; https://doi.org/10.1038/nrc2355
   PubMed Web of Science ®Google Scholar
• Kuwana Y , Asakura Y , Utsunomiya N , Nakanishi M , Arata Y , Itoh S , Nagase F , Kurosawa Y . Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions. Biochem Biophys Res Commun 1987; 149(3): 960-8; PMID:3122749; https://doi.org/10.1016/0006-291X(87)90502-X
   PubMed Web of Science ®Google Scholar
• Gross G , Waks T , Eshhar Z . Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci U S A 1989; 86(24): 10024-8; PMID:2513569; https://doi.org/10.1073/pnas.86.24.10024
   PubMed Web of Science ®Google Scholar
• Maude SL , Frey N , Shaw PA , Aplenc R , Barrett DM , Bunin NJ , Chew A , Gonzalez VE , Zheng Z , Lacey SF , et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 2014; 371(16): 1507-17; PMID:25317870; https://doi.org/10.1056/NEJMoa1407222
   PubMed Web of Science ®Google Scholar
• Lee DW , Kochenderfer JN , Stetler-Stevenson M , Cui YK , Delbrook C , Feldman SA , Fry TJ , Orentas R , Sabatino M , Shah NN , et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: A phase 1 dose-escalation trial. Lancet 2015; 385(9967): 517-28; PMID:25319501; https://doi.org/10.1016/S0140-6736(14)61403-3
   PubMed Web of Science ®Google Scholar
• Davila ML , Riviere I , Wang X , Bartido S , Park J , Curran K , Chung SS , Stefanski J , Borquez-Ojeda O , Olszewska M , et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med 2014; 6(224): 224ra25; PMID:24553386; https://doi.org/10.1126/scitranslmed.3008226
   PubMed Web of Science ®Google Scholar
• Kershaw MH , Westwood JA , Hwu P . Dual-specific T cells combine proliferation and antitumor activity. Nat Biotechnol 2002; 20(12): 1221-7; PMID:12415288; https://doi.org/10.1038/nbt756
   PubMed Web of Science ®Google Scholar
• Kershaw MH , Westwood JA , Parker LL , Wang G , Eshhar Z , Mavroukakis SA , White DE , Wunderlich JR , Canevari S , Rogers-Freezer L , et al. A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res 2006; 12(20 Pt 1): 6106-15; PMID:17062687; https://doi.org/10.1158/1078-0432.CCR-06-1183
   PubMed Web of Science ®Google Scholar
• Jessy T . Immunity over inability: The spontaneous regression of cancer. J Nat Sci Biol Med 2011; 2(1): 43-9; PMID:22470233; https://doi.org/10.4103/0976-9668.82318
   PubMedGoogle Scholar
• Oelschlaeger TA . Bacteria as tumor therapeutics? Bioeng Bugs 2010; 1(2): 146-7; PMID:21326940; https://doi.org/10.4161/bbug.1.2.11248
   PubMedGoogle Scholar
• McCarthy EF . The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 2006; 26:p. 154-8; PMID:16789469
   PubMedGoogle Scholar
• Mapara MY , Sykes M . Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol 2004; 22(6): 1136-51; PMID:15020616; https://doi.org/10.1200/JCO.2004.10.041
   PubMed Web of Science ®Google Scholar
• Medzhitov R . Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1(2): 135-45; PMID:11905821; https://doi.org/10.1038/35100529
   PubMed Web of Science ®Google Scholar
• Singh R , Dominiecki ME , Jaffee EM , Paterson Y . Fusion to listeriolysin O and delivery by listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J Immunol 2005; 175(6): 3663-73; PMID:16148111
   PubMed Web of Science ®Google Scholar
• Gunn GR , Zubair A , Peters C , Pan ZK , Wu TC , Paterson Y . Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001; 167(11): 6471-9; PMID:11714814
   PubMed Web of Science ®Google Scholar
• Chen Y , Yang D , Li S , Gao Y , Jiang R , Deng L , Frankel FR , Sun B . Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma. Oncogene 2012; 31(17): 2140-52; PMID:21927025; https://doi.org/10.1038/onc.2011.395
   PubMed Web of Science ®Google Scholar
• Pan ZK , Ikonomidis G , Lazenby A , Pardoll D , Paterson Y . A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med 1995; 1(5): 471-7; PMID:7585097
   PubMed Web of Science ®Google Scholar
• Liau LM , Jensen ER , Kremen TJ , Odesa SK , Sykes SN , Soung MC , Miller JF , Bronstein JM . Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Cancer Res 2002; 62(8): 2287-93; PMID:11956085
   PubMed Web of Science ®Google Scholar
• Brockstedt DG , Giedlin MA , Leong ML , Bahjat KS , Gao Y , Luckett W , Liu W , Cook DN , Portnoy DA , Dubensky TW, Jr . Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci U S A 2004; 101(38): 13832-7; PMID:15365184; https://doi.org/10.1073/pnas.0406035101
   PubMed Web of Science ®Google Scholar
• Le DT , Dubenksy TW, Jr , Brockstedt DG . Clinical development of Listeria monocytogenes-based immunotherapies. Semin Oncol 2012; 39(3): 311-22; PMID:22595054; https://doi.org/10.1053/j.seminoncol.2012.02.008
   PubMed Web of Science ®Google Scholar
• Xin G , Schauder DM , Jing W , Jiang A , Joshi NS , Johnson B , Cui W . Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors. Proc Natl Acad Sci U S A 2017; 114(4): 740-5; PMID:28069963; https://doi.org/10.1073/pnas.1614315114
   PubMed Web of Science ®Google Scholar
• Slaney CY , von Scheidt B , Davenport AJ , Beavis PA , Westwood JA , Mardiana S , Tscharke DC , Ellis S , Prince HM , Trapani JA , et al. Dual-specific chimeric antigen receptor T cells and an indirect vaccine eradicate a variety of large solid tumors in an immunocompetent, self-antigen setting. Clin Cancer Res 2017; 23(10): 2478-90; PMID:27965307; https://doi.org/10.1158/1078-0432.CCR-16-1860
   PubMed Web of Science ®Google Scholar